Aurora Labs Limited (FRA:0FR)
Germany flag Germany · Delayed Price · Currency is EUR
0.0245
+0.0055 (28.95%)
At close: Jan 9, 2026

Aurora Labs Statistics

Total Valuation

Aurora Labs has a market cap or net worth of EUR 15.93 million. The enterprise value is 15.81 million.

Market Cap15.93M
Enterprise Value 15.81M

Important Dates

The next estimated earnings date is Thursday, February 19, 2026.

Earnings Date Feb 19, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 523.36M
Shares Outstanding n/a
Shares Change (YoY) +36.17%
Shares Change (QoQ) +6.36%
Owned by Insiders (%) 9.47%
Owned by Institutions (%) 1.20%
Float 403.57M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 38.35
PB Ratio 26.61
P/TBV Ratio 26.61
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -7.55
EV / Sales 37.02
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -10.11

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.89.

Current Ratio 1.28
Quick Ratio 1.27
Debt / Equity 0.89
Debt / EBITDA n/a
Debt / FCF -0.34
Interest Coverage -75.83

Financial Efficiency

Return on equity (ROE) is -262.90% and return on invested capital (ROIC) is -123.58%.

Return on Equity (ROE) -262.90%
Return on Assets (ROA) -95.99%
Return on Invested Capital (ROIC) -123.58%
Return on Capital Employed (ROCE) -386.84%
Revenue Per Employee 31,942
Profits Per Employee -161,071
Employee Count13
Asset Turnover 0.25
Inventory Turnover n/a

Taxes

Income Tax -516,033
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -20.97% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -20.97%
50-Day Moving Average 0.02
200-Day Moving Average 0.02
Relative Strength Index (RSI) 53.37
Average Volume (20 Days) 13,100

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Aurora Labs had revenue of EUR 415,244 and -2.09 million in losses. Loss per share was -0.01.

Revenue415,244
Gross Profit 182,353
Operating Income -2.57M
Pretax Income -2.61M
Net Income -2.09M
EBITDA -2.54M
EBIT -2.57M
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 645,297 in cash and 533,694 in debt, with a net cash position of 111,602.

Cash & Cash Equivalents 645,297
Total Debt 533,694
Net Cash 111,602
Net Cash Per Share n/a
Equity (Book Value) 598,440
Book Value Per Share 0.00
Working Capital 265,697
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.46 million and capital expenditures -101,622, giving a free cash flow of -1.56 million.

Operating Cash Flow -1.46M
Capital Expenditures -101,622
Free Cash Flow -1.56M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 43.91%
Operating Margin -618.33%
Pretax Margin -628.54%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Aurora Labs does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -36.17%
Shareholder Yield -36.17%
Earnings Yield -13.15%
FCF Yield -9.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Aurora Labs has an Altman Z-Score of -15.36 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -15.36
Piotroski F-Score 3